BUSINESS● LOW1d ago · Oct 22, 2026, 9:37 PM
Moderna shares sink after leaked cancer data missed expectations
Financial Times · global
Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowLamu Refinery: Is Kenya ready to grant a fuel monopoly to Aliko Dangote?Jeune AfriqueBUSINESS34m agoJust Eat apologises after AI-generated images blunderAl Jazeera [en]